Patents by Inventor John P. Gibbs

John P. Gibbs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for Treating Psoriasis Using an Anti-IL-23 Antibody
    Publication number: 20220135668
    Abstract: The invention relates to products and methods for treating psoriasis. The products relate to antibodies that inhibit native human IL-23 while sparing IL-12. One example describes a Phase 1, randomized, double-blind, placebo-controlled, ascending single dose study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of an anti-IL-23 antibody (AMG 139) in healthy subjects and subjects with moderate to severe psoriasis.
    Type: Application
    Filed: January 13, 2022
    Publication date: May 5, 2022
    Inventors: John P. Gibbs, II, Wayne Tsuji, Wei-Jian Pan
  • METHODS OF TREATING OR PREVENTING CHOLESTEROL RELATED DISORDERS
    Publication number: 20210047434
    Abstract: The present invention relates to methods of treating or preventing cholesterol related disorders, such as hypercholesterolemia, hyperlipidemia or dyslipidemia, using antibodies against proprotein convertase subtilisin/kexin type 9 (PCSK9). Formulations and methods of producing said formulations are also described.
    Type: Application
    Filed: September 3, 2020
    Publication date: February 18, 2021
    Inventors: Joyce Chi Yee Chan, John P. Gibbs, Clapton S. Dias, Scott Wasserman, Robert Andrew Donald Scott, Christi L. Clogston, Timothy David Osslund, Evan A. Stein
  • Methods for Treating Psoriasis Using an Anti-IL-23 Antibody
    Publication number: 20200277368
    Abstract: The invention relates to products and methods for treating psoriasis. The products relate to antibodies that inhibit native human IL-23 while sparing IL-12. One example describes a Phase 1, randomized, double-blind, placebo-controlled, ascending single dose study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of an anti-IL-23 antibody (AMG 139) in healthy subjects and subjects with moderate to severe psoriasis.
    Type: Application
    Filed: October 10, 2019
    Publication date: September 3, 2020
    Inventors: John P. Gibbs, II, Wayne Tsuji, Wei-Jian Pan
  • METHODS FOR TREATING PSORIASIS USING AN ANTI-IL-23 ANTIBODY
    Publication number: 20160060337
    Abstract: The invention relates to products and methods for treating psoriasis. The products relate to antibodies that inhibit native human IL-23 while sparing IL-12. One example describes a Phase 1, randomized, double-blind, placebo-controlled, ascending single dose study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of an anti-IL-23 antibody (AMG 139) in healthy subjects and subjects with moderate to severe psoriasis.
    Type: Application
    Filed: February 25, 2014
    Publication date: March 3, 2016
    Inventors: John P. Gibbs, Wayne Tsuji, Wei-Jian Pan
  • METHODS FOR TREATING OR PREVENTING CHOLESTEROL RELATED DISORDERS
    Publication number: 20140004122
    Abstract: The present invention relates to methods of treating or preventing cholesterol related disorders, such as hypercholesterolemia, hyperlipidemia or dyslipidemia, using antibodies against proprotein convertase subtilisin/kexin type 9 (PCSK9). Formulations and methods of producing said formulations are also described.
    Type: Application
    Filed: June 28, 2013
    Publication date: January 2, 2014
    Applicant: AMGEN INC.
    Inventors: Joyce Chi Yee CHAN, John P. GIBBS, Clapton S. DIAS, Robert Andrew Donald SCOTT, Evan A. STEIN, Scott WASSERMAN
  • METHODS OF TREATING OR PREVENTING CHOLESTEROL RELATED DISORDERS
    Publication number: 20130064825
    Abstract: The present invention relates to methods of treating or preventing cholesterol related disorders, such as hypercholesterolemia, hyperlipidemia or dyslipidemia, using antibodies against proprotein convertase subtilisin/kexin type 9 (PCSK9). Formulations and methods of producing said formulations are also described.
    Type: Application
    Filed: May 10, 2012
    Publication date: March 14, 2013
    Applicant: Amgen Inc.
    Inventors: Joyce Chi Yee Chan, John P. Gibbs, Clapton S. Dias, Scott Wasserman, Robert Andrew Donald Scott, Christi L. Clogston, Timothy David Osslund